Rapamune
Rapamune, also known by its generic name sirolimus, is a medication used to prevent organ rejection in individuals who have received a kidney transplant. It belongs to a class of drugs called mTOR inhibitors. By suppressing the immune system, Rapamune helps the body accept the new kidney and reduces the risk of it being attacked by the recipient's own immune cells.
Beyond transplantation, Rapamune is also prescribed for other conditions. It is used in the treatment of certain
The way Rapamune works is by inhibiting a protein called mTOR (mammalian target of rapamycin), which plays
Rapamune is typically taken orally, in tablet or oral solution form. Like all medications, it can have